1. Clinical & Scientific Overview
Oral Isotretinoin (13-cis-Retinoic Acid) IP (TIP-MED-000393, Reference Code [10.16]-CMP123) is classified under
Vitamins, Minerals & Nutritional Supplements (Ch 10) as a Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidation Chain-Breaking Antioxidant (Schedule H / OTC | NLEM 2022 [Vit A]).
Within the Indian regulatory and compendial framework, it is governed under Non-Schedule / OTC or Schedule K Permitted Preparation (Medical Supervision Recommended for High-Dose/Therapeutic Regimens).
Co-indexed per approved Author Decision DEC-03 (Option 3A; displaced HTML [12.27] & Inventory CSV mono-14-12). Systemic retinoid (10/20 mg) for severe nodulocystic acne; Category X teratogen, contraindicated with Tetracyclines/Doxycycline (pseudotumor cerebri).
Standard approved strengths (refer to comparative context)
3. Mechanism of Action & Pharmacodynamics
Co-indexed per approved Author Decision DEC-03 (Option 3A; displaced HTML [12.27] & Inventory CSV mono-14-12). Systemic retinoid (10/20 mg) for severe nodulocystic acne; Category X teratogen, contraindicated with Tetracyclines/Doxycycline (pseudotumor cerebri).
4. Therapeutic Indications & Evidence-Supported Uses
- Vitamin A: Xerophthalmia / Bitot's spots / night blindness, National Prophylaxis Programme against Nutritional Blindness in children (9 months to 5 years every 6m), and severe Measles in children (2 doses of Vit A on Day 1 & Day 2 reduce measles mortality by 50%!)
- Vitamin E: Vitamin E deficiency, biopsy-proven non-diabetic NASH (800 IU/d), nocturnal leg cramps (with L-Carnitine), and cyclical mastalgia
🇮🇳 Jurisdiction & Indication Note: Indications and schedules reflect Indian compendial and regulatory records (CDSCO / Indian Pharmacopoeia & NFI / NLEM 2022). Where international reference labels (US FDA DailyMed / NCBI StatPearls) are cited for pharmacokinetic or mechanistic parameters, international approvals do not automatically imply CDSCO approval in India.
5. Educational Dosage Context, Formulations & Administration
Educational Dosing & Regimen Summary: Co-indexed per approved Author Decision DEC-03 (Option 3A; displaced HTML [12.27] & Inventory CSV mono-14-12). Systemic retinoid (10/20 mg) for severe nodulocystic acne; Category X teratogen, contraindicated with Tetracyclines/Doxycycline (pseudotumor cerebri).
Administration & Meal Timing: Take WITH or immediately after a fat-containing meal (both are fat-soluble vitamins requiring bile salts and dietary micelles for absorption) | Once Daily with Lunch or Dinner
6. Pharmacokinetics, Metabolism & Renal/Hepatic Adjustment
Comparative pharmacokinetic profile co-indexed under [10.16].
Renal: Avoid Vitamin A supplementation in chronic kidney disease / dialysis (renal clearance of retinol-binding protein is impaired in CKD, so extra Vit A causes bone toxicity & hypercalcaemia!). Hepatic: Contraindicated in hypervitaminosis A or severe liver disease
Renal: Avoid Vitamin A supplementation in chronic kidney disease / dialysis (renal clearance of retinol-binding protein is impaired in CKD, so extra Vit A causes bone toxicity & hypercalcaemia!). Hepatic: Contraindicated in hypervitaminosis A or severe liver disease
Renal: Avoid Vitamin A supplementation in chronic kidney disease / dialysis (renal clearance of retinol-binding protein is impaired in CKD, so extra Vit A causes bone toxicity & hypercalcaemia!). Hepatic: Contraindicated in hypervitaminosis A or severe liver disease
7. Contraindications, Precautions & High-Risk Warnings
- CRITICAL TERATOGENICITY WARNING FOR HIGH-DOSE VITAMIN A: Vitamin A doses >10,000 IU/day (such as Aquasol A 25,000 or 50,000 IU capsules!) are POTENT HUMAN TERATOGENS and are STRICTLY CONTRAINDICATED in pregnancy and women of childbearing potential! Also NEVER combine Vitamin A with Oral Isotretinoin or Acitretin! High-dose Vitamin E (>400 IU/day long-term) inhibits Vitamin K-dependent clotting factors
Key Clinical Precautions: Renal: Avoid Vitamin A supplementation in chronic kidney disease / dialysis (renal clearance of retinol-binding protein is impaired in CKD, so extra Vit A causes bone toxicity & hypercalcaemia!). Hepatic: Contraindicated in hypervitaminosis A or severe liver disease
8. Adverse Effects Profile
- Well tolerated at physiological doses
- Hypervitaminosis A: Acute (bulging fontanelle in infants, severe headache/vomiting from benign intracranial hypertension [pseudotumour cerebri], peeling skin); Chronic (hepatotoxicity/cirrhosis, bone pain, teratogenicity). High-dose Vitamin E (>800–1200 mg/d): Increased bleeding tendency
9. Major Drug–Drug, Drug–Food & Drug–Herb Interactions
- Vitamin A + Isotretinoin / Tetracyclines (Doxycycline/Minocycline) = Severe Pseudotumour Cerebri (benign intracranial hypertension with papilloedema & vision loss!); Orlistat, Cholestyramine, and Liquid Paraffin block absorption of Vitamins A & E; High-dose Vitamin E (>400 mg/d) potentiates Warfarin bleeding!
10. Clinical Monitoring, Patient Counselling & Storage
Clinical & Laboratory Monitoring: Monitor clinical parameters per parent class monograph [10.16].
Pharmacist Patient Counselling Points:
- Patient Counselling Checklist: THREE VITAL COUNTER RULES: (1) Never give high-strength Vitamin A capsules (Aquasol A 25,000/50,000 IU) to a pregnant woman or anyone taking Isotretinoin (Isotroin) or Doxycycline for acne; (2) Every child with Measles should receive 2 doses of Vitamin A (Day 1 & Day 2); (3) Avoid high-dose Evion (>400 mg) if taking Warfarin/Acitrom
- Meal & Clock Timing Instruction: Take WITH or immediately after a fat-containing meal (both are fat-soluble vitamins requiring bile salts and dietary micelles for absorption) (Once Daily with Lunch or Dinner)
- Missed Dose Protocol: Take with next meal if missed
- Geriatric Dispensing Pearl: Avoid Vitamin A supplements in older adults with CKD or osteoporosis (excess retinol increases hip fracture risk)
Storage, Stability & Dispensing Safeguards: Store below 25°C–30°C in original moisture- and light-resistant packaging out of reach of children. Available forms: Vitamin A Softgel Capsules: 25,000 IU, 50,000 IU; Oral Concentrate: 1,00,000 IU/mL. Vitamin E Softgel Capsules: 200 mg, 400 mg, 600 mg
11. Visual Pharmacology & Mechanism Diagram (svg-v339-01-adme-12-step-journey)
12. Authoritative References, Regulatory Sources & Editorial Disclaimer
Primary Compendial & Guideline Reference: Indian Pharmacopoeia (IP 2022) • NFI • CDSCO
Official Verification Portals: Indian Pharmacopoeia Commission (IPC) & National Formulary of India (NFI) • Central Drugs Standard Control Organization (CDSCO) • Ministry of Health & Family Welfare — NLEM 2022 • NCBI Bookshelf / StatPearls Pharmacology Reference • DailyMed (US FDA Official Prescribing Reference)
Last Medically & Pharmaceutically Reviewed: 2026-11-10 • Verification Status: VERIFIED_EDUCATIONAL_CONTENT
Educational & Clinical Disclaimer: This reference profile is published solely for pharmacy education, academic study, and professional clinical reference. It does not substitute for patient-specific clinical judgement, qualified specialist oncology/medical supervision, or official CDSCO/IP prescribing information. Never self-medicate with prescription, Schedule H/H1/X, NDPS, or oncology medicines.
13. Related Reference Monographs, Educational Guides & Visual Concept
💊 Related Pharmacological / Category Profiles
- [10.12] Thiamine Hydrochloride / Benfotiamine (Vitamin B1) — Essential Pyrophosphate Coenzyme for Carbohydrate Decarboxylation
- [10.13] Pyridoxine Hydrochloride (Vitamin B6) — Pyridoxal-5'-Phosphate (PLP) Coenzyme for Amino Acid & Neurotrans
- [10.16] Vitamin A (Retinol Palmitate) & Vitamin E (Tocopheryl Acetate) — Fat-Soluble Retinoid Epithelial/Visual Vitamin & Lipid-Peroxidati
- [10.17] Alpha-Lipoic Acid, Coenzyme Q10 (Ubidecarenone) & L-Carnitine — Mitochondrial Metabolic Coenzymes & Neuropathic/Myopathic Antioxi